Citations

Clear

58 citation(s) found for "Stallings, SC".

Does community engaged Carnegie status matter for county health rankings in the United States?
Apatu, Emma , Stallings‐Smith, Sericea , Anderson, Laura N. , Spaulding, Aaron , Spaulding, Aaron , Anderson, Laura , Álvarez, Elizabeth

Mayo Clinic

Journal of Public Health | May 21, 2019 | Volume: 43 | Issue: 1 | Pages: 164-171

10.1093/pubmed/fdz066 | PMID 31211380 Get It

Abstract Background Community engagement is commonly used to address social inequities. The Carnegie Foundation offers an optional designation for which U.S. colleges and universities may apply to facilitate better educational outcomes through the institutionalization of community engagement. This study is the first to examine the relationship between Carnegie community engaged status and community health outcomes. Methods Ordinal logistic regression was conducted to investigate the association between the presence of a community engaged institution and county health outcomes, including health behaviors, clinical care relating to access and quality, social and economic factors, and physical environment from the 2016 Robert Wood Johnson County Health Rankings and 2015 New England Resource Center for Higher Education Community engaged list. We examined 820 U.S. counties containing a university or college, 240 of which had a community engaged designation. Results Findings indicated that the presence of a community-engaged institution was positively associated with Clinical Care (OR = 1.99; 95% CI: 1.09, 3.64). Other county health factors were not similarly associated. Conclusions Our findings suggest that community engagement status may be most relevant for achieving better access and quality of clinical care. More research is needed to explore this association in the U.S. and internationally.
Quantitation of CD11c+ dendritic cells normal breast tissue and benign breast disease.
Arshad, Muhammad Asad, Visscher, Daniel W., Brahmbhatt, Rushin D., Jimenez, Alvaro Pena, Frost, Marlene H., Miller, Erin , Knutson, Keith L. , Hoskin, Tanya L. , Stallings‐Mann, Melody , Murphy, Linda, Winham, Stacey J. , Carter, Jodi M. , Radisky, Derek C. , Knutson, Keith L. , Degnim, Amy C.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e22115-e22115

10.1200/jco.2015.33.15_suppl.e22115 Get It

Enrichment sampling for a multi-site patient survey using electronic health records and census data
Mercaldo, Nathaniel D. , Brothers, Kyle B. , Connolly, John J. , Horowitz, Carol R. , Jarvik, Gail P. , Kitchner, Terrie, Li, Rongling, McCarty, Catherine A. , McManus, Valerie, Myers, Melanie F. , Pankratz, Joshua J., Shrubsole, Martha J. , Smith, Maureen E. , Stallings, Sarah , Williams, Janet L. , Schildcrout, Jonathan S. , McCormick, Jennifer B, Mercaldo, Nathaniel D , Myers, Melanie F , Shrubsole, Martha J , Schildcrout, Jonathan S , Jarvik, Gail P , Connolly, John J , Carrell, David , Clayton, Ellen Wright , Holm, Ingrid A. , McCormick, Jennifer Blair

Mayo Clinic

Journal of the American Medical Informatics Association | November 16, 2018 | Volume: 26 | Issue: 3 | Pages: 219-227

10.1093/jamia/ocy164 | PMID 30590688 Get It

Abstract Objective We describe a stratified sampling design that combines electronic health records (EHRs) and United States Census (USC) data to construct the sampling frame and an algorithm to enrich the sample with individuals belonging to rarer strata. Materials and Methods This design was developed for a multi-site survey that sought to examine patient concerns about and barriers to participating in research studies, especially among under-studied populations (eg, minorities, low educational attainment). We defined sampling strata by cross-tabulating several socio-demographic variables obtained from EHR and augmented with census-block-level USC data. We oversampled rarer and historically underrepresented subpopulations. Results The sampling strategy, which included USC-supplemented EHR data, led to a far more diverse sample than would have been expected under random sampling (eg, 3-, 8-, 7-, and 12-fold increase in African Americans, Asians, Hispanics and those with less than a high school degree, respectively). We observed that our EHR data tended to misclassify minority races more often than majority races, and that non-majority races, Latino ethnicity, younger adult age, lower education, and urban/suburban living were each associated with lower response rates to the mailed surveys. Discussion We observed substantial enrichment from rarer subpopulations. The magnitude of the enrichment depends on the accuracy of the variables that define the sampling strata and the overall response rate. Conclusion EHR and USC data may be used to define sampling strata that in turn may be used to enrich the final study sample. This design may be of particular interest for studies of rarer and understudied populations.
A case study evaluating the portability of an executable computable phenotype algorithm across multiple institutions and electronic health record environments
Pacheco, Jennifer A. , Rasmussen, Luke V. , Kiefer, Richard C. , Speltz, Peter, Carroll, Robert J. , Stallings, Sarah , Mo, Huan , Ahuja, Monika, Jiang, Guoqian , LaRose, Eric , Peissig, Peggy , Shang, Ning , Benoit, Barbara, Gainer, Vivian S., Borthwick, Kenneth M., Jackson, Kathryn , Sharma, Ambrish Kumar, Wu, Andy , Roden, Dan M. , Pathak, Jyotishman , Denny, Joshua C. , Thompson, William K. , Denny, Joshua C , Rasmussen, Luke V , Pacheco, Jennifer A , Campion, Thomas R , Wu, Andy Yizhou, Kho, Abel , Roden, Dan M.

Mayo Clinic

Journal of the American Medical Informatics Association | July 14, 2018 | Volume: 25 | Issue: 11 | Pages: 1540-1546

10.1093/jamia/ocy101 | PMID 30124903 Get It

Abstract Electronic health record (EHR) algorithms for defining patient cohorts are commonly shared as free-text descriptions that require human intervention both to interpret and implement. We developed the Phenotype Execution and Modeling Architecture (PhEMA, http://projectphema.org) to author and execute standardized computable phenotype algorithms. With PhEMA, we converted an algorithm for benign prostatic hyperplasia, developed for the electronic Medical Records and Genomics network (eMERGE), into a standards-based computable format. Eight sites (7 within eMERGE) received the computable algorithm, and 6 successfully executed it against local data warehouses and/or i2b2 instances. Blinded random chart review of cases selected by the computable algorithm shows PPV ≥90%, and 3 out of 5 sites had >90% overlap of selected cases when comparing the computable algorithm to their original eMERGE implementation. This case study demonstrates potential use of PhEMA computable representations to automate phenotyping across different EHR systems, but also highlights some ongoing challenges.
P4472Targeted sequencing of 80 pharmacogenes reveals evidence for pleiotropic effects on serum LDL cholesterol levels
Nikroo, Nikta Dadkhah, Austin, Erin , Li, R. , Robertson, Peggy D., Stallings, Sarah , Larson, Eric B. , Linneman, James G., Jarvik, G.P., Crosslin, David R. , Schaid, Daniel J. , Network, eMERGE, Safarova, Maya , Andrade, Mariza de , Carrell, David , Bielinski, Suzette J. , Kullo, Iftikhar J. , Network, eMERGE

Mayo Clinic

European Heart Journal | March 29, 2018 | Volume: 38 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehx504.p4472 Get It

A Soft Microenvironment Protects from Failure of Midbody Abscission and Multinucleation Downstream of the EMT-Promoting Transcription Factor Snail
Simi, Allison K., Anlaş, Alişya A. , Stallings‐Mann, Melody , Zhang, Sherry, Hsia, Tiffaney , Cichon, Magdalena A., Nelson, Celeste M. , Cichon, Magdalena, Radisky, Derek C.

Mayo Clinic

Cancer Research | February 26, 2018 | Volume: 78 | Issue: 9 | Pages: 2277-2289

10.1158/0008-5472.can-17-2899 | PMID 29483094 Get It

Abstract Multinucleation is found in more than one third of tumors and is linked to increased tolerance for mutation, resistance to chemotherapy, and invasive potential. The integrity of the genome depends on proper execution of the cell cycle, which can be altered through mechanotransduction pathways as the tumor microenvironment stiffens during tumorigenesis. Here, we show that signaling downstream of matrix metalloproteinase-3 (MMP3) or TGFβ, known inducers of epithelial–mesenchymal transition (EMT), also promotes multinucleation in stiff microenvironments through Snail-dependent expression of the filament-forming protein septin-6, resulting in midbody persistence, abscission failure, and multinucleation. Consistently, we observed elevated expression of Snail and septin-6 as well as multinucleation in a human patient sample of metaplastic carcinoma of the breast, a rare classification characterized by deposition of collagen fibers and active EMT. In contrast, a soft microenvironment protected mammary epithelial cells from becoming multinucleated by preventing Snail-induced upregulation of septin-6. Our data suggest that tissue stiffening during tumorigenesis synergizes with oncogenic signaling to promote genomic abnormalities that drive cancer progression. Significance: These findings reveal tissue stiffening during tumorigenesis synergizes with oncogenic signaling to promote genomic abnormalities that drive cancer progression. Cancer Res; 78(9); 2277–89. ©2018 AACR.
Macrophagic “Crown-like Structures” Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease
Carter, Jodi M. , Pena, Monica-Cătălina, Brahmbhatt, Rushin, Frost, Marlene H., Stallings‐Mann, Melody , Knutson, Keith L. , Visscher, Daniel W., Hoskin, Tanya L. , Pena, M Alvaro, Stallings-Mann, Melody, Radisky, Derek C. , Winham, Stacey J. , Knutson, Keith L. , Degnim, Amy C. , Carter, Jodi

Mayo Clinic

Cancer Prevention Research | November 22, 2017 | Volume: 11 | Issue: 2 | Pages: 113-119

10.1158/1940-6207.capr-17-0245 | PMID 29167285 Get It

Abstract In breast adipose tissue, macrophages that encircle damaged adipocytes form “crown-like structures of breast” (CLS-B). Although CLS-B have been associated with breast cancer, their role in benign breast disease (BBD) and early carcinogenesis is not understood. We evaluated breast biopsies from three age-matched groups (n = 86 each, mean age 55 years), including normal tissue donors of the Susan G. Komen for the Cure Tissue Bank (KTB), and subjects in the Mayo Clinic Benign Breast Disease Cohort who developed cancer (BBD cases) or did not develop cancer (BBD controls, median follow-up 14 years). Biopsies were classified into histologic categories, and CD68-immunostained tissue sections were evaluated for the frequency and density of CLS-B. Our data demonstrate that CLS-B are associated with BBD: CLS-B–positive samples were significantly less frequent among KTB biopsies (3/86, 3.5%) than BBD controls (16/86 = 18.6%, P = 0.01) and BBD cases (21/86 = 24%, P = 0.002). CLS-B were strongly associated with body mass index (BMI); BMI < 25: 7% CLS-B positive, BMI 25–29: 13%, and BMI ≥ 30: 29% (P = 0.0005). Among BBD biopsies, a high CLS-B count [>5 CLS-B/sample: 10.5% (BBD cases) vs 4.7% (BBD controls), P = 0.007] conferred a breast cancer OR of 6.8 (95% CI, 1.4–32.4), P = 0.02, after adjusting for adipose tissue area (cm2), histologic impression, and BMI. As high CLS-B densities are independently associated with an increased breast cancer risk, they may be a promising histologic marker of breast cancer risk in BBD. Cancer Prev Res; 11(2); 113–9. ©2017 AACR.
Abstract 4253: Expression profiling of paired benign and breast cancer lesions in African American women
Holowatyj, Andreana N. , Ali‐Fehmi, Rouba , Mehner, Christine , Mann, Melody Stallings, Ruterbusch, Julie J. , Bandyopadhyay, Subhayu , Dyson, Gregory , Radisky, Derek C. , Coté, Michele L.

Mayo Clinic

Cancer Research | July 31, 2017 | Volume: 77 | Issue: 13_Supplement | Pages: 4253-4253

10.1158/1538-7445.am2017-4253 Get It

Abstract Benign breast disease, a known risk factor for subsequent breast cancer, includes a histological spectrum of lesions that can be subdivided based on the overall impression into non-proliferative lesions, proliferative lesions without atypia, and atypical hyperplasia. Yet little is known about the molecular characteristics of benign breast tissue from African American women, who suffer from disproportionately high breast cancer mortality rates. 72 breast samples from African American women were obtained. RNA was extracted from archival formalin-fixed, paraffin-embedded (FFPE) blocks. Gene expression profiling was performed on these samples using the Affymetrix HTA2.0 exon array chip. A fit linear model using generalized least squares identified probe sets with differential expression in benign-in situ and benign-invasive breast cancer paired lesions. 36 benign and 36 breast cancer paired lesions were included in the study. In the benign-in situ set (n=20), 978 probe sets were differentially expressed (threshold: fold-change, 1.50; p < 0.05). Probe sets mapped to 125 annotated genes, of which 69 (55.2%) were involved in cancer. The benign-invasive set (n=52) identified 351 differentially expressed probe sets that mapped to 84 annotated genes, of which 61 (72.6%) had known cancer significance. Genes involved in cellular growth and proliferation were significantly over-expressed in both benign-in situ and benign-invasive lesions (p-values < 0.0104). In the population of 36 paired samples, differentially expressed genes were found to regulate the estrogen receptor (ESR1) through distinct network associations. Many genes are differentially expressed by benign and breast cancer lesions, and in situ/invasive histology contribute to the distinct molecular characteristics and pathways of breast malignancy. Our findings highlight the first study to assess expression profiling of paired benign and breast cancer lesions among African American women. Citation Format: Andreana Natalie Holowatyj, Julie J. Ruterbusch, Rouba Ali-Fehmi, Sudeshna Bandyopadhyay, Christine Mehner, Melody Stallings Mann, Gregory Dyson, Derek Radisky, Michele L. Cote. Expression profiling of paired benign and breast cancer lesions in African American women [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 4253. doi:10.1158/1538-7445.AM2017-4253
Healthcare Provider Education to Support Integration of Pharmacogenomics in Practice: The Emerge Network Experience
Vitek, Carolyn R. Rohrer , Abul‐Husn, Noura S. , Connolly, John J. , Hartzler, Andrea L. , Kitchner, Terrie, Peterson, Josh F. , Rasmussen, Luke V. , Smith, Maureen E. , Stallings, Sarah , Wolf, Wendy A. , Prows, Cynthia A. , Rohrer Vitek, Carolyn R, Williams, Marc S , Rasmussen, Luke V , Connolly, John J , Peterson, Josh F

Mayo Clinic

Pharmacogenomics | June 22, 2017 | Volume: 18 | Issue: 10 | Pages: 1013-1025

10.2217/pgs-2017-0038 | PMID 28639489 Get It

Gene signature model for breast cancer risk prediction for women with sclerosing adenosis.
Anderson, S. Keith , Oberg, Ann L. , Frank, Ryan D. , Frost, Marlene H., Visscher, Daniel W., Radisky, Derek C. , Degnim, Amy C. , Nassar, Aziza , Stallings‐Mann, Melody , Winham, Stacey J. , Vierkant, Robert A. , Wang, Chen

Mayo Clinic

Journal of Clinical Oncology | February 24, 2017 | Volume: 33 | Issue: 28_suppl | Pages: 18-18

10.1200/jco.2015.33.28_suppl.18 Get It

18 Background: Benign breast disease (BBD) is diagnosed in 1-2 million women/year in the US, and while these patients are known to be at substantially increased risk for subsequent development of breast cancer, existing models for risk assessment perform poorly at the individual level. Here, we describe a DNA-microarray-based transcriptional model for breast cancer risk prediction for patients with sclerosing adenosis (SA), a lesion found in ¼ of all BBD patients that is characterized by epithelial proliferation, disordered acinar architecture, and stromal fibrosis. Methods: A training set was developed from 86 patients diagnosed with sclerosing adenosis (SA), of which 27 subsequently developed cancer within 10 years (cases) and 59 remained cancer-free at 10 years (controls). A diagonal linear discriminate analysis (DLDA)-prediction model for prediction of cancer within 10 years (SA TTC10) was generated from transcriptional profiles of formalin fixed, paraffin-embedded (FFPE) biopsy-derived RNA. This model was tested on a separate validation case-control set composed of 65 SA patients. Results: The SA TTC10 gene signature model, composed of 35 gene features, achieved a clear and significant separation between case and control with receiver operating characteristic area under the curve of 0.913 in the training set and 0.836 in the validation set. Conclusions: Our results provide the first demonstration that benign breast tissue contains transcriptional alterations that indicate risk of breast cancer development, and that essential precursor biomarkers of malignancy are present many years prior to cancer development. Furthermore, the SA TTC10 gene signature model, which can be assessed on FFPE biopsies, constitutes a novel prognostic biomarker for patients with SA.